| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | hyaluronic acid binding | 4.73e-07 | 29 | 109 | 5 | GO:0005540 | |
| GeneOntologyMolecularFunction | peptidase activity | CPXM2 PRSS12 NPEPPS RHBDL1 F2 F11 MEP1B YOD1 TINAG CAPN7 PRSS21 TNFAIP3 TMPRSS11A | 5.78e-05 | 654 | 109 | 13 | GO:0008233 |
| GeneOntologyMolecularFunction | frizzled binding | 8.01e-05 | 42 | 109 | 4 | GO:0005109 | |
| GeneOntologyMolecularFunction | carbohydrate:monoatomic cation symporter activity | 1.02e-04 | 17 | 109 | 3 | GO:0005402 | |
| GeneOntologyMolecularFunction | bisphosphoglycerate mutase activity | 1.76e-04 | 4 | 109 | 2 | GO:0004082 | |
| GeneOntologyMolecularFunction | 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity | 1.76e-04 | 4 | 109 | 2 | GO:0046538 | |
| GeneOntologyMolecularFunction | phosphoglycerate mutase activity | 1.76e-04 | 4 | 109 | 2 | GO:0004619 | |
| GeneOntologyMolecularFunction | N-acetyllactosamine synthase activity | 2.92e-04 | 5 | 109 | 2 | GO:0003945 | |
| GeneOntologyMolecularFunction | scavenger receptor activity | 4.21e-04 | 27 | 109 | 3 | GO:0005044 | |
| GeneOntologyMolecularFunction | endopeptidase activity | 5.85e-04 | 430 | 109 | 9 | GO:0004175 | |
| GeneOntologyMolecularFunction | D-glucose:sodium symporter activity | 6.09e-04 | 7 | 109 | 2 | GO:0005412 | |
| GeneOntologyMolecularFunction | serine-type endopeptidase activity | 6.17e-04 | 190 | 109 | 6 | GO:0004252 | |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 6.75e-04 | 268 | 109 | 7 | GO:0005539 | |
| GeneOntologyMolecularFunction | serine-type peptidase activity | 9.64e-04 | 207 | 109 | 6 | GO:0008236 | |
| GeneOntologyMolecularFunction | serine hydrolase activity | 1.09e-03 | 212 | 109 | 6 | GO:0017171 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 1.21e-03 | 85 | 109 | 4 | GO:0038024 | |
| GeneOntologyMolecularFunction | carbohydrate transmembrane transporter activity | 1.56e-03 | 42 | 109 | 3 | GO:0015144 | |
| GeneOntologyMolecularFunction | intramolecular phosphotransferase activity | 1.57e-03 | 11 | 109 | 2 | GO:0016868 | |
| GeneOntologyBiologicalProcess | positive regulation of neuroblast proliferation | 3.16e-06 | 44 | 107 | 5 | GO:0002052 | |
| GeneOntologyBiologicalProcess | regulation of nervous system development | FXR2 WNT7B HAPLN4 HAPLN2 F2 CLSTN1 ITGAX HAPLN1 KIAA0319 FXR1 VCAN LRP1 HAPLN3 PLXNB3 | 4.32e-06 | 625 | 107 | 14 | GO:0051960 |
| GeneOntologyBiologicalProcess | regulation of neurogenesis | FXR2 WNT7B HAPLN4 HAPLN2 F2 HAPLN1 KIAA0319 FXR1 VCAN LRP1 HAPLN3 PLXNB3 | 1.49e-05 | 515 | 107 | 12 | GO:0050767 |
| GeneOntologyBiologicalProcess | regulation of neuroblast proliferation | 2.56e-05 | 67 | 107 | 5 | GO:1902692 | |
| GeneOntologyBiologicalProcess | positive regulation of neural precursor cell proliferation | 6.04e-05 | 80 | 107 | 5 | GO:2000179 | |
| GeneOntologyBiologicalProcess | positive regulation of nervous system development | FXR2 HAPLN4 HAPLN2 CLSTN1 HAPLN1 FXR1 VCAN LRP1 HAPLN3 PLXNB3 | 6.41e-05 | 418 | 107 | 10 | GO:0051962 |
| GeneOntologyBiologicalProcess | regulation of translation at presynapse, modulating synaptic transmission | 7.97e-05 | 3 | 107 | 2 | GO:0099577 | |
| GeneOntologyBiologicalProcess | regulation of translation at presynapse | 7.97e-05 | 3 | 107 | 2 | GO:0140244 | |
| GeneOntologyBiologicalProcess | positive regulation of neurogenesis | 9.55e-05 | 354 | 107 | 9 | GO:0050769 | |
| GeneOntologyBiologicalProcess | protein K33-linked deubiquitination | 1.59e-04 | 4 | 107 | 2 | GO:1990168 | |
| GeneOntologyBiologicalProcess | regulation of axon extension involved in regeneration | 1.59e-04 | 4 | 107 | 2 | GO:0048690 | |
| GeneOntologyBiologicalProcess | neuroblast proliferation | 2.09e-04 | 104 | 107 | 5 | GO:0007405 | |
| GeneOntologyBiologicalProcess | protein K29-linked deubiquitination | 2.64e-04 | 5 | 107 | 2 | GO:0035523 | |
| GeneOntologyBiologicalProcess | chemoattraction of axon | 2.64e-04 | 5 | 107 | 2 | GO:0061642 | |
| GeneOntologyBiologicalProcess | axon extension involved in regeneration | 2.64e-04 | 5 | 107 | 2 | GO:0048677 | |
| GeneOntologyBiologicalProcess | regulation of sprouting of injured axon | 2.64e-04 | 5 | 107 | 2 | GO:0048686 | |
| GeneOntologyCellularComponent | perineuronal net | 9.08e-10 | 10 | 110 | 5 | GO:0072534 | |
| GeneOntologyCellularComponent | perisynaptic extracellular matrix | 1.66e-09 | 11 | 110 | 5 | GO:0098966 | |
| GeneOntologyCellularComponent | synapse-associated extracellular matrix | 4.58e-09 | 13 | 110 | 5 | GO:0099535 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | HAPLN4 HAPLN2 F2 FCN3 LGALS3BP HAPLN1 TINAG VCAN FIBCD1 HAPLN3 FGL1 USH2A | 2.30e-05 | 530 | 110 | 12 | GO:0062023 |
| GeneOntologyCellularComponent | external encapsulating structure | HAPLN4 HAPLN2 F2 FCN3 PKHD1L1 LGALS3BP HAPLN1 TINAG VCAN FIBCD1 HAPLN3 FGL1 USH2A | 4.26e-05 | 658 | 110 | 13 | GO:0030312 |
| GeneOntologyCellularComponent | extracellular matrix | HAPLN4 HAPLN2 F2 FCN3 LGALS3BP HAPLN1 TINAG VCAN FIBCD1 HAPLN3 FGL1 USH2A | 1.76e-04 | 656 | 110 | 12 | GO:0031012 |
| GeneOntologyCellularComponent | cluster of actin-based cell projections | 1.17e-03 | 223 | 110 | 6 | GO:0098862 | |
| Domain | LINK | 6.65e-09 | 13 | 106 | 5 | SM00445 | |
| Domain | Link_dom | 6.65e-09 | 13 | 106 | 5 | IPR000538 | |
| Domain | Xlink | 6.65e-09 | 13 | 106 | 5 | PF00193 | |
| Domain | LINK_1 | 6.65e-09 | 13 | 106 | 5 | PS01241 | |
| Domain | LINK_2 | 6.65e-09 | 13 | 106 | 5 | PS50963 | |
| Domain | Wnt | 3.56e-06 | 19 | 106 | 4 | IPR005817 | |
| Domain | Wnt_CS | 3.56e-06 | 19 | 106 | 4 | IPR018161 | |
| Domain | wnt | 3.56e-06 | 19 | 106 | 4 | PF00110 | |
| Domain | WNT1 | 3.56e-06 | 19 | 106 | 4 | SM00097 | |
| Domain | WNT1 | 3.56e-06 | 19 | 106 | 4 | PS00246 | |
| Domain | FXR_C1 | 3.19e-05 | 2 | 106 | 2 | PF16096 | |
| Domain | FXR_C1 | 3.19e-05 | 2 | 106 | 2 | IPR032172 | |
| Domain | CTDL_fold | 3.29e-05 | 107 | 106 | 6 | IPR016187 | |
| Domain | IGv | 6.74e-05 | 75 | 106 | 5 | SM00406 | |
| Domain | FXMRP1_C_core | 9.54e-05 | 3 | 106 | 2 | IPR022034 | |
| Domain | Agenet-like_dom | 9.54e-05 | 3 | 106 | 2 | IPR008395 | |
| Domain | Agenet | 9.54e-05 | 3 | 106 | 2 | PF05641 | |
| Domain | FXMRP1_C_core | 9.54e-05 | 3 | 106 | 2 | PF12235 | |
| Domain | AGENET_LIKE | 9.54e-05 | 3 | 106 | 2 | PS51641 | |
| Domain | TRYPSIN_SER | 1.60e-04 | 90 | 106 | 5 | IPR033116 | |
| Domain | Fibrinogen_CS | 1.61e-04 | 19 | 106 | 3 | IPR020837 | |
| Domain | Ig-like_fold | HAPLN4 HAPLN2 TMIGD3 FCRLA PKHD1L1 HAPLN1 KIAA0319 PIGR VCAN HAPLN3 USH2A CEACAM20 PLXNB3 | 1.80e-04 | 706 | 106 | 13 | IPR013783 |
| Domain | Coact_PPARg | 1.90e-04 | 4 | 106 | 2 | IPR026784 | |
| Domain | Phosphogly_mut1 | 1.90e-04 | 4 | 106 | 2 | IPR005952 | |
| Domain | SRCR | 2.19e-04 | 21 | 106 | 3 | PF00530 | |
| Domain | - | 2.28e-04 | 97 | 106 | 5 | 3.10.100.10 | |
| Domain | C-type_lectin-like/link | 2.51e-04 | 99 | 106 | 5 | IPR016186 | |
| Domain | TRYPSIN_HIS | 3.02e-04 | 103 | 106 | 5 | IPR018114 | |
| Domain | Fibrinogen_a/b/g_C_2 | 3.30e-04 | 24 | 106 | 3 | IPR014715 | |
| Domain | - | 3.30e-04 | 24 | 106 | 3 | 4.10.530.10 | |
| Domain | TRYPSIN_SER | 3.44e-04 | 106 | 106 | 5 | PS00135 | |
| Domain | TRYPSIN_HIS | 3.60e-04 | 107 | 106 | 5 | PS00134 | |
| Domain | SR | 3.73e-04 | 25 | 106 | 3 | SM00202 | |
| Domain | - | 3.73e-04 | 25 | 106 | 3 | 3.10.250.10 | |
| Domain | - | HAPLN4 HAPLN2 TMIGD3 FCRLA PKHD1L1 HAPLN1 PIGR VCAN HAPLN3 USH2A CEACAM20 PLXNB3 | 3.79e-04 | 663 | 106 | 12 | 2.60.40.10 |
| Domain | SRCR_1 | 4.20e-04 | 26 | 106 | 3 | PS00420 | |
| Domain | SRCR_2 | 4.20e-04 | 26 | 106 | 3 | PS50287 | |
| Domain | SRCR-like_dom | 4.20e-04 | 26 | 106 | 3 | IPR017448 | |
| Domain | Peptidase_S1A | 4.62e-04 | 113 | 106 | 5 | IPR001314 | |
| Domain | SRCR | 4.71e-04 | 27 | 106 | 3 | IPR001190 | |
| Domain | Fibrinogen_C | 4.71e-04 | 27 | 106 | 3 | PF00147 | |
| Domain | Abhydro_lipase | 4.72e-04 | 6 | 106 | 2 | PF04083 | |
| Domain | AB_hydrolase_lipase | 4.72e-04 | 6 | 106 | 2 | IPR006693 | |
| Domain | Lipase_euk | 4.72e-04 | 6 | 106 | 2 | IPR025483 | |
| Domain | TRYPSIN_DOM | 5.01e-04 | 115 | 106 | 5 | PS50240 | |
| Domain | Tryp_SPc | 5.42e-04 | 117 | 106 | 5 | SM00020 | |
| Domain | FBG | 5.83e-04 | 29 | 106 | 3 | SM00186 | |
| Domain | Trypsin | 6.32e-04 | 121 | 106 | 5 | PF00089 | |
| Domain | Trypsin_dom | 6.32e-04 | 121 | 106 | 5 | IPR001254 | |
| Domain | V-set | 6.36e-04 | 184 | 106 | 6 | PF07686 | |
| Domain | - | 6.45e-04 | 30 | 106 | 3 | 3.90.215.10 | |
| Domain | Fibrinogen_a/b/g_C_1 | 6.45e-04 | 30 | 106 | 3 | IPR014716 | |
| Domain | Galactosyl_T | 6.58e-04 | 7 | 106 | 2 | IPR003859 | |
| Domain | Glyco_transf_7C | 6.58e-04 | 7 | 106 | 2 | PF02709 | |
| Domain | Glyco_transf_7N | 6.58e-04 | 7 | 106 | 2 | PF13733 | |
| Domain | Galactosyl_T_C | 6.58e-04 | 7 | 106 | 2 | IPR027791 | |
| Domain | Galactosyl_T_N | 6.58e-04 | 7 | 106 | 2 | IPR027995 | |
| Domain | Peptidase_S1_PA | 6.81e-04 | 123 | 106 | 5 | IPR009003 | |
| Domain | FIBRINOGEN_C_1 | 7.82e-04 | 32 | 106 | 3 | PS00514 | |
| Domain | Fibrinogen_a/b/g_C_dom | 7.82e-04 | 32 | 106 | 3 | IPR002181 | |
| Domain | FIBRINOGEN_C_2 | 7.82e-04 | 32 | 106 | 3 | PS51406 | |
| Domain | Na/solute_symporter_CS | 8.74e-04 | 8 | 106 | 2 | IPR018212 | |
| Domain | Ig_V-set | 9.57e-04 | 199 | 106 | 6 | IPR013106 | |
| Domain | PG/BPGM_mutase_AS | 1.12e-03 | 9 | 106 | 2 | IPR001345 | |
| Domain | - | 1.17e-03 | 81 | 106 | 4 | 3.90.550.10 | |
| Domain | PGAM | 1.39e-03 | 10 | 106 | 2 | SM00855 | |
| Domain | PG_MUTASE | 1.39e-03 | 10 | 106 | 2 | PS00175 | |
| Domain | Nucleotide-diphossugar_trans | 1.59e-03 | 88 | 106 | 4 | IPR029044 | |
| Domain | NA_SOLUT_SYMP_1 | 1.70e-03 | 11 | 106 | 2 | PS00456 | |
| Domain | NA_SOLUT_SYMP_2 | 2.03e-03 | 12 | 106 | 2 | PS00457 | |
| Domain | SSF | 2.03e-03 | 12 | 106 | 2 | PF00474 | |
| Domain | Na/solute_symporter | 2.03e-03 | 12 | 106 | 2 | IPR001734 | |
| Domain | NA_SOLUT_SYMP_3 | 2.03e-03 | 12 | 106 | 2 | PS50283 | |
| Domain | His_Phos_1 | 2.03e-03 | 12 | 106 | 2 | PF00300 | |
| Domain | His_Pase_superF_clade-1 | 2.03e-03 | 12 | 106 | 2 | IPR013078 | |
| Domain | Ig-like_dom | 2.26e-03 | 503 | 106 | 9 | IPR007110 | |
| Domain | NCD3G | 2.39e-03 | 13 | 106 | 2 | PF07562 | |
| Domain | GPCR_3_9-Cys_dom | 2.39e-03 | 13 | 106 | 2 | IPR011500 | |
| Domain | OTU | 2.39e-03 | 13 | 106 | 2 | PF02338 | |
| Domain | IG | 2.75e-03 | 421 | 106 | 8 | SM00409 | |
| Domain | Ig_sub | 2.75e-03 | 421 | 106 | 8 | IPR003599 | |
| Domain | MORN | 2.78e-03 | 14 | 106 | 2 | SM00698 | |
| Domain | PIN_domain-like | 2.78e-03 | 14 | 106 | 2 | IPR029060 | |
| Domain | GPCR_3_CS | 2.78e-03 | 14 | 106 | 2 | IPR017979 | |
| Domain | OTU | 3.19e-03 | 15 | 106 | 2 | PS50802 | |
| Domain | MORN | 3.19e-03 | 15 | 106 | 2 | IPR003409 | |
| Domain | MORN | 3.19e-03 | 15 | 106 | 2 | PF02493 | |
| Domain | OTU_dom | 3.19e-03 | 15 | 106 | 2 | IPR003323 | |
| Domain | Kringle | 4.10e-03 | 17 | 106 | 2 | IPR000001 | |
| Domain | Kringle_CS | 4.10e-03 | 17 | 106 | 2 | IPR018056 | |
| Domain | KRINGLE_2 | 4.10e-03 | 17 | 106 | 2 | PS50070 | |
| Domain | Kringle | 4.10e-03 | 17 | 106 | 2 | PF00051 | |
| Domain | KRINGLE_1 | 4.10e-03 | 17 | 106 | 2 | PS00021 | |
| Domain | KR | 4.10e-03 | 17 | 106 | 2 | SM00130 | |
| Domain | His_PPase_superfam | 5.67e-03 | 20 | 106 | 2 | IPR029033 | |
| Domain | - | 5.67e-03 | 20 | 106 | 2 | 3.40.50.1240 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_WNT_ACYLATION | 2.29e-06 | 19 | 72 | 4 | M47836 | |
| Pathway | REACTOME_WNT_LIGAND_BIOGENESIS_AND_TRAFFICKING | 7.30e-06 | 25 | 72 | 4 | MM14940 | |
| Pathway | REACTOME_WNT_LIGAND_BIOGENESIS_AND_TRAFFICKING | 8.59e-06 | 26 | 72 | 4 | M27239 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_WNT_INHIBITOR | 1.17e-05 | 28 | 72 | 4 | M47835 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PTCH1_TO_HEDGEHOG_SIGNALING_PATHWAY | 1.35e-05 | 29 | 72 | 4 | M47372 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_SMO_TO_HEDGEHOG_SIGNALING_PATHWAY | 1.35e-05 | 29 | 72 | 4 | M47377 | |
| Pathway | KEGG_MEDICUS_VARIANT_FZD7_OVEREXPRESSION_TO_WNT_SIGNALING_PATHWAY | 3.64e-05 | 37 | 72 | 4 | M47411 | |
| Pathway | KEGG_MEDICUS_VARIANT_LRP6_OVEREXPRESSION_TO_WNT_SIGNALING_PATHWAY | 7.96e-05 | 45 | 72 | 4 | M47412 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_PATHWAY | 8.68e-05 | 46 | 72 | 4 | M47409 | |
| Pathway | REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS | 1.16e-04 | 94 | 72 | 5 | M797 | |
| Pathway | KEGG_BASAL_CELL_CARCINOMA | 1.75e-04 | 55 | 72 | 4 | M17807 | |
| Pathway | KEGG_HEDGEHOG_SIGNALING_PATHWAY | 1.88e-04 | 56 | 72 | 4 | M1053 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BLOOD_GROUP_H_O_ANTIGEN_TYPE_2_BIOSYNTHESIS | 5.31e-04 | 7 | 72 | 2 | M47965 | |
| Pathway | KEGG_MEDICUS_REFERENCE_II_BLOOD_GROUP_ANTIGEN_BIOSYNTHESIS | 5.31e-04 | 7 | 72 | 2 | M47968 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LECTIN_PATHWAY_OF_COAGULATION_CASCADE_PROTHROMBIN_TO_THROMBIN | 7.06e-04 | 8 | 72 | 2 | M47784 | |
| Pathway | WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY | 9.27e-04 | 85 | 72 | 4 | M48315 | |
| Pubmed | 9.47e-11 | 4 | 110 | 4 | 12663660 | ||
| Pubmed | 1.96e-08 | 10 | 110 | 4 | 20950796 | ||
| Pubmed | 1.23e-07 | 4 | 110 | 3 | 12732630 | ||
| Pubmed | Wnt family proteins are secreted and associated with the cell surface. | 2.18e-07 | 17 | 110 | 4 | 8167409 | |
| Pubmed | Mapping of Wnt-Frizzled interactions by multiplex CRISPR targeting of receptor gene families. | 2.18e-07 | 17 | 110 | 4 | 28733458 | |
| Pubmed | Coronary Artery Formation Is Driven by Localized Expression of R-spondin3. | 3.54e-07 | 19 | 110 | 4 | 28834739 | |
| Pubmed | The WNT7b promoter is regulated by TTF-1, GATA6, and Foxa2 in lung epithelium. | 5.44e-07 | 21 | 110 | 4 | 11914369 | |
| Pubmed | Epithelial Wnt10a Is Essential for Tooth Root Furcation Morphogenesis. | 5.44e-07 | 21 | 110 | 4 | 31914354 | |
| Pubmed | 6.11e-07 | 6 | 110 | 3 | 14550776 | ||
| Pubmed | 6.63e-07 | 22 | 110 | 4 | 18991257 | ||
| Pubmed | 8.01e-07 | 23 | 110 | 4 | 27362799 | ||
| Pubmed | 1.57e-06 | 27 | 110 | 4 | 17804636 | ||
| Pubmed | 1.83e-06 | 28 | 110 | 4 | 20940229 | ||
| Pubmed | Ectodermal Wnt signaling regulates abdominal myogenesis during ventral body wall development. | 1.83e-06 | 28 | 110 | 4 | 24394376 | |
| Pubmed | Wnt5a potentiates TGF-β signaling to promote colonic crypt regeneration after tissue injury. | 2.12e-06 | 29 | 110 | 4 | 22956684 | |
| Pubmed | 2.12e-06 | 29 | 110 | 4 | 18364260 | ||
| Pubmed | 2.44e-06 | 30 | 110 | 4 | 19282366 | ||
| Pubmed | Atlas of Wnt and R-spondin gene expression in the developing male mouse lower urogenital tract. | 2.44e-06 | 30 | 110 | 4 | 21936019 | |
| Pubmed | 2.44e-06 | 30 | 110 | 4 | 15880404 | ||
| Pubmed | Overactive Wnt5a signaling disrupts hair follicle polarity during mouse skin development. | 2.44e-06 | 30 | 110 | 4 | 36305473 | |
| Pubmed | SUMF2 CPXM2 WNT9B TMIGD3 SHISA2 FCRLA FCN3 CPED1 ZDHHC4 PRSS21 FIBCD1 HAPLN3 CEACAM20 B4GALT4 | 2.88e-06 | 985 | 110 | 14 | 12975309 | |
| Pubmed | Expression patterns of Wnt genes during development of an anterior part of the chicken eye. | 3.63e-06 | 10 | 110 | 3 | 16258938 | |
| Pubmed | 4.60e-06 | 35 | 110 | 4 | 30940800 | ||
| Pubmed | 4.60e-06 | 35 | 110 | 4 | 19185060 | ||
| Pubmed | Integrated analysis of Wnt signalling system component gene expression. | 5.77e-06 | 37 | 110 | 4 | 35831952 | |
| Pubmed | Wnt11 promotes cardiomyocyte development by caspase-mediated suppression of canonical Wnt signals. | 6.44e-06 | 38 | 110 | 4 | 21041481 | |
| Pubmed | 6.44e-06 | 38 | 110 | 4 | 23190887 | ||
| Pubmed | 7.15e-06 | 39 | 110 | 4 | 24586192 | ||
| Pubmed | Isolation of a cDNA encoding the muscle-specific subunit of human phosphoglycerate mutase. | 9.91e-06 | 2 | 110 | 2 | 2822696 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 27419389 | ||
| Pubmed | Phosphoglycerate mutase isozyme marker for tissue differentiation in man. | 9.91e-06 | 2 | 110 | 2 | 4827367 | |
| Pubmed | Comparative genomic sequence analysis of the FXR gene family: FMR1, FXR1, and FXR2. | 9.91e-06 | 2 | 110 | 2 | 11735223 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 10198161 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 30125937 | ||
| Pubmed | Thrombogenic potential of picomolar coagulation factor XIa is mediated by thrombin wave propagation. | 9.91e-06 | 2 | 110 | 2 | 36724509 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 15072993 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 31752995 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 21072162 | ||
| Pubmed | Activation of factor XI by products of prothrombin activation. | 9.91e-06 | 2 | 110 | 2 | 21527525 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 10823824 | ||
| Pubmed | Reduced expression of the hyaluronan and proteoglycan link proteins in malignant gliomas. | 9.91e-06 | 2 | 110 | 2 | 19633295 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 10196376 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 37467891 | ||
| Pubmed | 1.17e-05 | 44 | 110 | 4 | 23884445 | ||
| Pubmed | Homeodomain-mediated beta-catenin-dependent switching events dictate cell-lineage determination. | 1.52e-05 | 47 | 110 | 4 | 16678101 | |
| Pubmed | Stromal R-spondin orchestrates gastric epithelial stem cells and gland homeostasis. | 1.52e-05 | 47 | 110 | 4 | 28813421 | |
| Pubmed | 1.52e-05 | 47 | 110 | 4 | 33141892 | ||
| Pubmed | 1.67e-05 | 16 | 110 | 3 | 10585256 | ||
| Pubmed | 1.67e-05 | 16 | 110 | 3 | 9889131 | ||
| Pubmed | Wnt antagonist SFRP3 inhibits the differentiation of mouse hepatic progenitor cells. | 1.80e-05 | 49 | 110 | 4 | 19562671 | |
| Pubmed | 1.85e-05 | 257 | 110 | 7 | 16335952 | ||
| Pubmed | 2.87e-05 | 19 | 110 | 3 | 11520664 | ||
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 33914812 | ||
| Pubmed | Fragile X-related proteins regulate mammalian circadian behavioral rhythms. | 2.97e-05 | 3 | 110 | 2 | 18589395 | |
| Pubmed | Distinct interaction of versican/PG-M with hyaluronan and link protein. | 2.97e-05 | 3 | 110 | 2 | 12888576 | |
| Pubmed | Link protein has greater affinity for versican than aggrecan. | 2.97e-05 | 3 | 110 | 2 | 14724283 | |
| Pubmed | Spatial control of nucleoporin condensation by fragile X-related proteins. | 2.97e-05 | 3 | 110 | 2 | 32706158 | |
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 12417522 | ||
| Pubmed | The fragile X mental retardation syndrome protein interacts with novel homologs FXR1 and FXR2. | 2.97e-05 | 3 | 110 | 2 | 7489725 | |
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 8668200 | ||
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 12821648 | ||
| Pubmed | Factor XI activation in a revised model of blood coagulation. | 2.97e-05 | 3 | 110 | 2 | 1652157 | |
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 15590670 | ||
| Pubmed | Phosphoglycerate Mutase Cooperates with Chk1 Kinase to Regulate Glycolysis. | 2.97e-05 | 3 | 110 | 2 | 32634742 | |
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 14620382 | ||
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 27770568 | ||
| Pubmed | Mouse phosphoglycerate mutase M and B isozymes: cDNA cloning, enzyme activity assay and mapping. | 2.97e-05 | 3 | 110 | 2 | 11250083 | |
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 28761320 | ||
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 19487368 | ||
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 17822691 | ||
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 11560994 | ||
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 20442204 | ||
| Pubmed | LLPS of FXR proteins drives replication organelle clustering for β-coronaviral proliferation. | 2.97e-05 | 3 | 110 | 2 | 38587486 | |
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 10888599 | ||
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 17155964 | ||
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 28767039 | ||
| Pubmed | Developmental activation of phosphoglycerate mutase-2 in the testis of the mouse. | 2.97e-05 | 3 | 110 | 2 | 2824255 | |
| Pubmed | Evidence that fragile X mental retardation protein is a negative regulator of translation. | 2.97e-05 | 3 | 110 | 2 | 11157796 | |
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 36088585 | ||
| Pubmed | Fragile X-related protein family: a double-edged sword in neurodevelopmental disorders and cancer. | 2.97e-05 | 3 | 110 | 2 | 32878499 | |
| Pubmed | Accumulated common variants in the broader fragile X gene family modulate autistic phenotypes. | 2.97e-05 | 3 | 110 | 2 | 26612855 | |
| Pubmed | Differential expression of FMR1, FXR1 and FXR2 proteins in human brain and testis. | 2.97e-05 | 3 | 110 | 2 | 9259278 | |
| Pubmed | Soluble Receptors Affecting Stroke Outcomes: Potential Biomarkers and Therapeutic Tools. | 2.97e-05 | 3 | 110 | 2 | 33498620 | |
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 20352152 | ||
| Pubmed | 3.93e-05 | 21 | 110 | 3 | 26459142 | ||
| Pubmed | Fragile X related protein 1 (FXR1P) regulates proliferation of adult neural stem cells. | 5.92e-05 | 4 | 110 | 2 | 28204491 | |
| Pubmed | 5.92e-05 | 4 | 110 | 2 | 8626514 | ||
| Pubmed | 5.92e-05 | 4 | 110 | 2 | 11027579 | ||
| Pubmed | 5.92e-05 | 4 | 110 | 2 | 10567518 | ||
| Pubmed | 5.92e-05 | 4 | 110 | 2 | 25956706 | ||
| Pubmed | 5.92e-05 | 4 | 110 | 2 | 14585507 | ||
| Pubmed | Utility of molecular testing for related retinal dystrophies. | 5.92e-05 | 4 | 110 | 2 | 16767206 | |
| Pubmed | 5.92e-05 | 4 | 110 | 2 | 16571602 | ||
| Pubmed | 5.92e-05 | 4 | 110 | 2 | 20032510 | ||
| Pubmed | 5.92e-05 | 4 | 110 | 2 | 18664458 | ||
| Pubmed | 5.92e-05 | 4 | 110 | 2 | 21427223 | ||
| Pubmed | 5.92e-05 | 4 | 110 | 2 | 25195573 | ||
| Pubmed | 5.92e-05 | 4 | 110 | 2 | 20876097 | ||
| Pubmed | 5.92e-05 | 4 | 110 | 2 | 10556305 | ||
| Pubmed | Wnt and Bmp signalling cooperatively regulate graded Emx2 expression in the dorsal telencephalon. | 9.85e-05 | 5 | 110 | 2 | 12070081 | |
| Cytoband | 7p22.1 | 2.01e-04 | 47 | 110 | 3 | 7p22.1 | |
| GeneFamily | Wnt family|Endogenous ligands | 7.64e-07 | 19 | 70 | 4 | 360 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 3.99e-05 | 163 | 70 | 6 | 590 | |
| GeneFamily | Bisphosphoglycerate phosphatases | 8.82e-05 | 4 | 70 | 2 | 1082 | |
| GeneFamily | Fibrinogen C domain containing | 1.20e-04 | 25 | 70 | 3 | 554 | |
| GeneFamily | Low density lipoprotein receptors | 1.12e-03 | 13 | 70 | 2 | 634 | |
| GeneFamily | Proteases, serine | 1.87e-03 | 63 | 70 | 3 | 738 | |
| GeneFamily | Cadherin related | 1.94e-03 | 17 | 70 | 2 | 24 | |
| GeneFamily | OTU domain containing | 1.94e-03 | 17 | 70 | 2 | 669 | |
| GeneFamily | Beta 4-glycosyltransferases | 1.94e-03 | 17 | 70 | 2 | 425 | |
| GeneFamily | Polypeptide N-acetylgalactosaminyltransferases | 2.68e-03 | 20 | 70 | 2 | 433 | |
| GeneFamily | Lipases|Arylacetamide deacetylase family | 3.25e-03 | 22 | 70 | 2 | 464 | |
| GeneFamily | Zinc fingers DHHC-type|Ankyrin repeat domain containing | 3.86e-03 | 24 | 70 | 2 | 76 | |
| Coexpression | NABA_PROTEOGLYCANS | 3.49e-07 | 35 | 110 | 5 | M5882 | |
| Coexpression | NABA_PROTEOGLYCANS | 4.04e-07 | 36 | 110 | 5 | MM17061 | |
| Coexpression | NABA_MATRISOME | PRSS12 WNT7B WNT8B WNT9A WNT9B HAPLN4 HAPLN2 F2 FCN3 HAPLN1 MEP1B TINAG VCAN HAPLN3 FGL1 USH2A PLXNB3 | 1.31e-06 | 1026 | 110 | 17 | M5889 |
| Coexpression | DESCARTES_ORGANOGENESIS_EPENDYMAL_CELL | 3.06e-06 | 282 | 110 | 9 | MM3642 | |
| Coexpression | NABA_MATRISOME | PRSS12 WNT7B WNT8B WNT9A WNT9B HAPLN4 HAPLN2 F2 HAPLN1 MEP1B TINAG VCAN HAPLN3 FGL1 PLXNB3 | 2.08e-05 | 1008 | 110 | 15 | MM17056 |
| Coexpression | NABA_CORE_MATRISOME | 2.16e-05 | 275 | 110 | 8 | M5884 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.14e-07 | 169 | 110 | 7 | f00741203efa0b948db7223ee8c19bdd0918258a | |
| ToppCell | droplet-Fat-Mat-18m-Epithelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.51e-06 | 156 | 110 | 6 | cfd7f56f3155db677684827607e9008e975dbe70 | |
| ToppCell | droplet-Fat-Mat-18m-Epithelial-epithelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.51e-06 | 156 | 110 | 6 | 0d79b4172896574b00faf00e87254f68d76f5512 | |
| ToppCell | droplet-Fat-Mat-18m-Epithelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.51e-06 | 156 | 110 | 6 | f09150aacb6121f913648ed3918f9cd4f22c61f2 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_P4HA3|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.01e-06 | 161 | 110 | 6 | 0d05aa57312b095752fe13333b2def5f5b1cc83e | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Epcam____brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.72e-06 | 167 | 110 | 6 | ed7e785dcd25777f64e0c2596ada4f5a5ea17121 | |
| ToppCell | droplet-Marrow-nan-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.72e-06 | 180 | 110 | 6 | 64f01494a4052186773720e10b4e7c724ff94547 | |
| ToppCell | LV-10._Endothelium_II|World / Chamber and Cluster_Paper | 7.12e-06 | 187 | 110 | 6 | 7876dcb4800c2e54874df3d933efb79307a64a97 | |
| ToppCell | moderate-Myeloid-Monocyte-derived_Macrophage|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.53e-06 | 193 | 110 | 6 | 22455801194bd8c73c5c397f5eac4f723429c383 | |
| ToppCell | critical-Myeloid-Monocyte-derived_Macrophage|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.78e-06 | 194 | 110 | 6 | e36d1fd141bdcbd9ed66a33de6cdfde77189a0c1 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-CD4_INF-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.01e-05 | 199 | 110 | 6 | d3f36ede2fade550ec8f21a0448e71e1ff579ee2 | |
| ToppCell | Striatum-Hematopoietic-MICROGLIA-MI2(C1qb)-MICROGLIA_Microglia.C1qb.Tmem119_(Microglia.C1qb.Tmem119)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 3.41e-05 | 74 | 110 | 4 | e89506bd854a43b80f839ace36f7a3eaa8437215 | |
| ToppCell | Striatum-Hematopoietic-MICROGLIA-MI2(C1qb)|Striatum / BrainAtlas - Mouse McCarroll V32 | 3.41e-05 | 74 | 110 | 4 | 0dbce0b36eaf0c7a8b623478c85d1cac82c6693a | |
| ToppCell | Striatum-Hematopoietic-MICROGLIA-MI2(C1qb)-MICROGLIA_Microglia.C1qb.Tmem119_(Microglia.C1qb.Tmem119)|Striatum / BrainAtlas - Mouse McCarroll V32 | 3.41e-05 | 74 | 110 | 4 | 093575ea862f3724d236817f04d98cc06b8addf0 | |
| ToppCell | Striatum-Hematopoietic-MICROGLIA|Striatum / BrainAtlas - Mouse McCarroll V32 | 3.41e-05 | 74 | 110 | 4 | 89effada90fbfef1844a905d3f82e9d16666eea5 | |
| ToppCell | Striatum-Hematopoietic-MICROGLIA-MI2(C1qb)-MICROGLIA_Microglia.C1qb.Tmem119_(Microglia.C1qb.Tmem119)--|Striatum / BrainAtlas - Mouse McCarroll V32 | 3.41e-05 | 74 | 110 | 4 | b14a950b90791a4cc5ffd29eb75a524abdd382da | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Myeloid-plasmacytoid_dendritic_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.42e-05 | 157 | 110 | 5 | fc127e7720649e746f3d3f5c2e9e63784767106a | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Myeloid-plasmacytoid_dendritic_cells|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.42e-05 | 157 | 110 | 5 | 66a191cef4aa00811bb04462310d012610006f85 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_vein-D122|Adult / Lineage, Cell type, age group and donor | 4.84e-05 | 160 | 110 | 5 | 0cfe130606af433b2aa90e0a20b6c44659dd6fd4 | |
| ToppCell | BAL-Mild-cDC_5|Mild / Compartment, Disease Groups and Clusters | 4.98e-05 | 161 | 110 | 5 | 7a6e8ed0b5d999efce8945d8083ab01d71be9a92 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.76e-05 | 166 | 110 | 5 | c215c4aede38d355d35fd26cd7ef2c19efecd0e6 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-plasmacytoid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.10e-05 | 168 | 110 | 5 | e156297a7515e785a9e79a9676700bd3a9d92b98 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Plasmacytoid_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.10e-05 | 168 | 110 | 5 | 32e0bc0873baa13027241063283ef26d2aab56f5 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.10e-05 | 168 | 110 | 5 | 4ae9e9d93bcd6f4d5815e57fd5afa7a3398a0ec1 | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-enterocyte_of_epithelium_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.10e-05 | 168 | 110 | 5 | 03896466698a79f7f1ad862cb7e05585260e2a5a | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Myeloid-plasmacytoid_dendritic_cells|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.10e-05 | 168 | 110 | 5 | e8878ec68b21c8d5694d7209b816d2f869673164 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.10e-05 | 168 | 110 | 5 | 04e168fe1d6f5f9e3d3bf9d7c13e800e3594868a | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Myeloid-plasmacytoid_dendritic_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.10e-05 | 168 | 110 | 5 | a007758c219d3d5db2b5529f29af63be0d408304 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.27e-05 | 169 | 110 | 5 | 454b92b9b67299a64278c010db033ca5b9d217a0 | |
| ToppCell | facs-Heart-LA-18m-Myeloid-macrophage|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.27e-05 | 169 | 110 | 5 | 421fb287c7e439d1870b7950c5e3ca34106e014a | |
| ToppCell | facs-Heart-LA-18m-Myeloid-macrophage|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.27e-05 | 169 | 110 | 5 | 383639ec4f9d0c6255e0881edca15cdd1980a37c | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Myeloid_Dendritic_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.27e-05 | 169 | 110 | 5 | 735655e75511c5c41aca667909e8bb52a0ad7fc6 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage-macrophage,_alveolar-Macro_c3-EREG|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.45e-05 | 170 | 110 | 5 | 9ac1ef57f14418a5dd2aa16861c3df698c28f5ed | |
| ToppCell | Immune_cells-Dendritic_cells|World / Lineage and Cell class | 6.45e-05 | 170 | 110 | 5 | 094dc211d80c89ecb1010855f1fe6eeb71bf0e20 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-Epcam____brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.63e-05 | 171 | 110 | 5 | 8e7223ba447947cdf4e1c82a52fd90439cf3d8f6 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-plasmacytoid_dendritic_cell-plasmacytoid_dendritic|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.82e-05 | 172 | 110 | 5 | 422d311bba2dd5d8bece4e96ee8c86e78086b62d | |
| ToppCell | normal_Pleural_Fluid-Myeloid_cells-CD1c+_DCs|normal_Pleural_Fluid / Location, Cell class and cell subclass | 6.82e-05 | 172 | 110 | 5 | 200b2e63313b110b8ca59ee5b72c02cc8ed907cd | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-plasmacytoid_dendritic_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.82e-05 | 172 | 110 | 5 | 1abb6fbb28c8aff384540493d0f70eeacaa751f4 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-plasmacytoid_dendritic_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.01e-05 | 173 | 110 | 5 | 4f0c065e876197ad8cae7856669f09e37ecafa3f | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-plasmacytoid_dendritic_cell-plasmacytoid_dendritic|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.01e-05 | 173 | 110 | 5 | 9bbea566964281f47bf75d665b7d69ba8326e207 | |
| ToppCell | droplet-Marrow-BM-30m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.60e-05 | 176 | 110 | 5 | d4075796c38b775fe721abb47426e662a0d415e3 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_vein|Adult / Lineage, Cell type, age group and donor | 7.60e-05 | 176 | 110 | 5 | 043683c61c5d1a7f8a4666a612310246bd3d83a2 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.61e-05 | 185 | 110 | 5 | 6da9a06e1514d5d5f47359a14637f02539846096 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.61e-05 | 185 | 110 | 5 | 4a188e2566a75d1b4f3c879a8c241c277c4b451c | |
| ToppCell | COVID-19-Endothelial_cells-Pulmonary_venous_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 1.01e-04 | 187 | 110 | 5 | 2d20193a6cacdfa4877457c97b0077408942186c | |
| ToppCell | PND07-28-samps-Mesenchymal-Matrix_fibroblast|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.06e-04 | 189 | 110 | 5 | dc5164591dea45b420798b94dda211be03daa70c | |
| ToppCell | 390C-Myeloid-Macrophage-FABP4+_Macrophage_2|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.06e-04 | 189 | 110 | 5 | 3b5e1a8d5c1e1fa2124f64f212e9c6b8f1b7d7da | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.12e-04 | 191 | 110 | 5 | 3379d145d34f89150f7b06d1340022cfc6b4a6ce | |
| ToppCell | CV-Healthy-1|Healthy / Virus stimulation, Condition and Cluster | 1.14e-04 | 192 | 110 | 5 | 2a2052b44e8f679ef484f03ba4fb37b0ec841b88 | |
| ToppCell | Adult-Immune-alveolar_macrophage_(MARCO_positive)-D175|Adult / Lineage, Cell type, age group and donor | 1.14e-04 | 192 | 110 | 5 | 733491e932350e3c216a626cc49c3cd3fe970a82 | |
| ToppCell | 390C-Myeloid-Macrophage-FABP4+_Macrophage_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.17e-04 | 193 | 110 | 5 | c9cf5a661294a947d06d53d18d47362c0e0b6ef5 | |
| ToppCell | NS-critical-d_07-13-Myeloid-Monocyte-derived_Macrophage|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.17e-04 | 193 | 110 | 5 | 0dd83b21e164147abfd511a927615c40a28781a2 | |
| ToppCell | IPF-Endothelial|IPF / Disease state, Lineage and Cell class | 1.20e-04 | 194 | 110 | 5 | 9591993aa2dcba3d09a0f1ea8b8f2439c26482d6 | |
| ToppCell | control-Myeloid-Neutrophils_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.20e-04 | 194 | 110 | 5 | 267e213e8efe53aadfe553a2ca010a0e3b4b8939 | |
| ToppCell | Adult-Endothelial|Adult / Lineage, Cell type, age group and donor | 1.20e-04 | 194 | 110 | 5 | 963b3fbee0575af8379baa397ace65949eaf34f7 | |
| ToppCell | Children_(3_yrs)-Immune-alveolar_macrophage_(MARCO_positive)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.23e-04 | 195 | 110 | 5 | 9d649ac7d2af313481069c95349efc0c68449e2b | |
| ToppCell | moderate-Myeloid-Monocyte-derived_Macrophage|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.23e-04 | 195 | 110 | 5 | 9c9634906168239cf978adb398787692437bf9e7 | |
| ToppCell | severe-Classical_Monocyte|World / disease stage, cell group and cell class | 1.23e-04 | 195 | 110 | 5 | cf638aac4d57ae0774008920a1a5e9dfd8c73885 | |
| ToppCell | NS-moderate-d_07-13|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.23e-04 | 195 | 110 | 5 | 088209505a68519ec89f50f0576096da6966bf17 | |
| ToppCell | 3'_v3-blood-Lymphocytic_NK-NK_CD56bright_CD16-|blood / Manually curated celltypes from each tissue | 1.23e-04 | 195 | 110 | 5 | 1470f562ebcfe7da367964ecfd6c7f43bcdb4a73 | |
| ToppCell | Adult-Immune-alveolar_macrophage_(MARCO_positive)|Adult / Lineage, Cell type, age group and donor | 1.23e-04 | 195 | 110 | 5 | 55e25f702af19146a161861cfd15f40bbda1dc35 | |
| ToppCell | distal-Hematologic-EREG+_Dendritic-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.26e-04 | 196 | 110 | 5 | c17bb7b3992bfec194bfa310f201a5c64b35868e | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_monocytic-classical_monocyte|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.26e-04 | 196 | 110 | 5 | 28e9e191361966df3a9bd48450090577aa72a999 | |
| ToppCell | distal-Hematologic-EREG+_Dendritic|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.26e-04 | 196 | 110 | 5 | 14c6870d125fc2bdacf4199883399cec0dd3f569 | |
| ToppCell | COPD-Stromal-Fibroblast|Stromal / Disease state, Lineage and Cell class | 1.26e-04 | 196 | 110 | 5 | 4930eeb303d174c28fd91021723e26fdf1af9170 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Myeloid-Monocytic-Classical_Monocyte-Mono_c2-CD14-HLA-DPB1|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.26e-04 | 196 | 110 | 5 | 5bcb57c57d5da0440220a1133a96aa89407bd871 | |
| ToppCell | Mild-CD4+_T_activated|World / Disease group and Cell class | 1.26e-04 | 196 | 110 | 5 | 417b4fc2e4388f34c410576131b02936f93e46b6 | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_pulmonary_venous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.29e-04 | 197 | 110 | 5 | b0036cf3f7e6edf8e43f16cd2f0f0e80471d2576 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.29e-04 | 197 | 110 | 5 | eb07545bef5ad506fbbe3a1f99131f26c1447a31 | |
| ToppCell | NS-moderate-d_07-13-Myeloid-Non-resident_Macrophage|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.29e-04 | 197 | 110 | 5 | 774a5053f43ac7d614c127ae7363d32a3a194f63 | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_airway_ciliated-Deuterosomal|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.29e-04 | 197 | 110 | 5 | 1ffbbe44db0fd3ebd91ad16ab0b91153de5d7c6d | |
| ToppCell | severe-HLA-DR+_CD83+_Monocyte|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.32e-04 | 198 | 110 | 5 | a77f3440d7fb6a50066abc7e9ad59e83798ef13d | |
| ToppCell | Control_saline-Epithelial_airway|Control_saline / Treatment groups by lineage, cell group, cell type | 1.32e-04 | 198 | 110 | 5 | e6863238e022ecfb6a8e3f4b7661b376e92c5d8f | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial|Control_saline / Treatment groups by lineage, cell group, cell type | 1.32e-04 | 198 | 110 | 5 | e7aa42e5fbd42c68f50cda4a8f3aa464c862c007 | |
| ToppCell | Caecum-(6)_Macrophage-(61)_LYVE1_Macrophage|Caecum / shred on region, Cell_type, and subtype | 1.32e-04 | 198 | 110 | 5 | e684c3934c163aef4d284b69435832d2c9614f2a | |
| ToppCell | Caecum-Macrophage-LYVE1_Macrophage|Caecum / Region, Cell class and subclass | 1.32e-04 | 198 | 110 | 5 | a92c0cacb775aca6bbb302bd9e22c081a112a44d | |
| ToppCell | control-CD163+_Monocytes_(Sample_ID1_d7)|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.35e-04 | 199 | 110 | 5 | 933201d32eda12a89660bdbae9114a95cc428a38 | |
| ToppCell | Bronchial-NucSeq-Endothelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.35e-04 | 199 | 110 | 5 | 36a230b80096455df26c2e2c8c05fd6b231508c5 | |
| ToppCell | Parenchymal-NucSeq-Endothelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.35e-04 | 199 | 110 | 5 | a4a9a1c2a34b5a8318a55d1211d6c8661ca9793e | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-myeloid|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.35e-04 | 199 | 110 | 5 | 0f3ce61bbae69f7e333ed8dacf7257645624e163 | |
| ToppCell | kidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.35e-04 | 199 | 110 | 5 | 174f6013af6eafa577f84205a62927f2b367fda3 | |
| ToppCell | Sepsis-URO|Sepsis / Disease, condition lineage and cell class | 1.35e-04 | 199 | 110 | 5 | 8e6dac82d1d0e759cd567f9c95b70cb4801d7caf | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.35e-04 | 199 | 110 | 5 | 137ff58897e6ada8a5a70205f66fe9110795506b | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Macrophage_other-Macrophage_intermediate|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.35e-04 | 199 | 110 | 5 | ccd473accf2205c120c0d32031619e421558a861 | |
| ToppCell | Parenchyma_Control_(B.)-Immune-TX-MoAM-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.38e-04 | 200 | 110 | 5 | 59b2ebb69699c9bebf8c2697eb678fdccd0a998c | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.38e-04 | 200 | 110 | 5 | 96701a4d57753f5ec0dd5c7550054bbcc946bc5f | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.38e-04 | 200 | 110 | 5 | a4ec0e80f5422b91b85264a9bb74568dd577e285 | |
| ToppCell | Lung_Parenchyma-Control-Myeloid-MoAM-MoAM-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.38e-04 | 200 | 110 | 5 | 390f9429feae991b8524e2815d8fcd4914c74459 | |
| ToppCell | Lung_Parenchyma-Control-Myeloid-MoAM-MoAM|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.38e-04 | 200 | 110 | 5 | f7e9b4a8ededb116774528b38ea3381b6f05915c | |
| ToppCell | Lung_Parenchyma-Control-Myeloid-MoAM|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.38e-04 | 200 | 110 | 5 | d98c523ac0e4767aaeef50cae142513d115212ab | |
| ToppCell | COVID_non-vent|World / Disease condition, Lineage, Cell class and subclass | 1.38e-04 | 200 | 110 | 5 | accef1050963dc91e189ac3d38228f15bf57e06e | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Airway|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.53e-04 | 124 | 110 | 4 | a7b7d8b14d1218194da8fcf69b4780b6e9469332 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Bcl6-Excitatory_Neuron.Slc17a7.Bcl6-Pvalb_(Layer_5a)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.72e-04 | 51 | 110 | 3 | 28d6b12c44ad308560931d275e0dd0243a555bf3 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th-Inhibitory_Neuron.Th-Slc17a6-Lpl_(VTA_(ventral_VTA))-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 3.05e-04 | 53 | 110 | 3 | 605cd3214c1c17a11b69ca65b44c4a3a322f3fbb | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th-Inhibitory_Neuron.Th-Slc17a6-Lpl_(VTA_(ventral_VTA))|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 3.05e-04 | 53 | 110 | 3 | e7f69a8b4dab2d63da84b7aaa7e192c8e19a06ad | |
| ToppCell | LPS-IL1RA-Hematopoietic_Mast-Mast_cells-Mast-cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.91e-04 | 139 | 110 | 4 | f1d1a51a79afdddc82e73cd29b3240e3e973db28 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_DC-DC-DC3|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.91e-04 | 139 | 110 | 4 | c320847311ba9a844fc4760251372a2a9152787b | |
| ToppCell | facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.70e-04 | 146 | 110 | 4 | 74009a2921359a8352afbaea8c325a3743622543 | |
| ToppCell | facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.70e-04 | 146 | 110 | 4 | cb19f2bb6832d11fe69b670df49eac096a378a9d | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.95e-04 | 148 | 110 | 4 | 438fe292d29be0206e1d9fd59ede5f8368f13665 | |
| Drug | Coagulation Factor IX | 3.39e-06 | 7 | 106 | 3 | DB00100 | |
| Disease | malignant pleural mesothelioma (implicated_via_orthology) | 3.68e-05 | 3 | 104 | 2 | DOID:7474 (implicated_via_orthology) | |
| Disease | fragile X syndrome (implicated_via_orthology) | 3.68e-05 | 3 | 104 | 2 | DOID:14261 (implicated_via_orthology) | |
| Disease | Moyamoya disease | 3.82e-04 | 40 | 104 | 3 | MONDO_0016820 | |
| Disease | Hypercalcemia | 9.36e-04 | 13 | 104 | 2 | C0020437 | |
| Disease | Milk-Alkali Syndrome | 9.36e-04 | 13 | 104 | 2 | C0026141 | |
| Disease | thrombosis (is_implicated_in) | 1.25e-03 | 15 | 104 | 2 | DOID:0060903 (is_implicated_in) | |
| Disease | glomerulonephritis (is_marker_for) | 2.02e-03 | 19 | 104 | 2 | DOID:2921 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EDHNYETGECWNGLW | 156 | Q96KX2 | |
| GYFWWSGRVDDVANA | 461 | Q6P461 | |
| NYWGWGGEDDDIFNR | 306 | P15291 | |
| AWRNGFDQCDYGWLS | 286 | P13611 | |
| WEIAMLGYACQGNEW | 216 | Q8N4J0 | |
| DWREITWQPHNCQYG | 741 | A4D0V7 | |
| NNYWGWGGEDDDLRL | 251 | O60513 | |
| QGEGPYCNRTWDGWL | 66 | P30988 | |
| EGALTSNWEQWDTYC | 81 | Q8IUR6 | |
| WNWVGTIAADDDYGR | 206 | P41180 | |
| RNDTGPYACEVWNWG | 316 | Q6UY09 | |
| PYACEVWNWGSRARS | 321 | Q6UY09 | |
| VSGYQWCDIENCVKW | 316 | P24864 | |
| YWWCTNVVLRGVEEN | 101 | Q3MIX3 | |
| CTPGWQGWNNRIEYE | 261 | O94985 | |
| WICWFAALAAGGAYI | 706 | A7MBM2 | |
| DGAWCAGRNDLQQWI | 181 | Q8N436 | |
| LAKDGEYCWRWTGFN | 401 | Q96IK5 | |
| WRRWWCDAVLYGEQG | 501 | P20702 | |
| NQEYCDWIKRDDTWG | 206 | Q5VVQ6 | |
| YNQEGTCWYEGDWVQ | 196 | P0C881 | |
| YNQEGTCWYEGDWVQ | 196 | B2RC85 | |
| GAWWYASCYRSNLNG | 251 | O75636 | |
| YHAGQWGTVCDDQWD | 296 | P56730 | |
| WGCYTEQQRCDGYWH | 386 | Q9Y561 | |
| LFRAWEEGLDWCNAG | 201 | Q96S86 | |
| WCNAGWLQDATVQYP | 211 | Q96S86 | |
| YRGQWGTVCDNLWDL | 41 | Q08380 | |
| EVYSRANEQEPCGWW | 76 | P51116 | |
| SQLYQAWTEGLDWCN | 181 | Q9GZV7 | |
| EVYSRANDQEPCGWW | 66 | P51114 | |
| AVDWIAGNIYWTDQG | 1971 | Q07954 | |
| GLAVDWVGGNLYWCD | 3106 | Q07954 | |
| WVGGNLYWCDKGRDT | 3111 | Q07954 | |
| FNYGPWADRQRDCLW | 341 | Q2LD37 | |
| CGRGWLNQDDVWVNY | 406 | Q5VW00 | |
| YDVWLGNSRGNTWAR | 111 | P07098 | |
| CGRAGQLNQWLWSYE | 506 | Q9ULL4 | |
| SNGSREECYWGHVFW | 286 | Q32M88 | |
| DDEDCYGNVSWPGWR | 341 | Q6A1A2 | |
| ADEAWCQARGLNWAA | 541 | Q8TE96 | |
| WSDEFGSWQEYGRQG | 381 | Q9H0J9 | |
| CVAEQQGRWRGWYTY | 191 | Q9BV87 | |
| LCWGWFSVAANGSVY | 861 | Q9BYE9 | |
| DNGIFWISWDDLCQY | 516 | Q9Y6W3 | |
| GSYWCEAATEDNQVW | 236 | Q7L513 | |
| GNCAEEDQSGWWFNR | 246 | Q08830 | |
| ELAVDGFNWELWCRY | 321 | Q9NY28 | |
| GFNWELWCRYDALPQ | 326 | Q9NY28 | |
| DWVCGGQWNAMLGYL | 136 | Q9NX05 | |
| AAQGFDWELWCRYLN | 296 | Q6P9A2 | |
| DRNVIYTDCWVTGWG | 506 | P03951 | |
| YDLWTGIQWGAQVCF | 336 | Q96GR2 | |
| ADDYQQKRWSWGGSA | 156 | Q8IWC1 | |
| HSENNCAAFYRGAWW | 396 | Q8N539 | |
| LDWCNAGWLRDGSVQ | 206 | Q86UW8 | |
| CGRGWLNHNDFWVNY | 406 | Q5VU92 | |
| VCDWLGFSYREEVQW | 166 | Q5VZK9 | |
| VQEAYNTWPSCWGGR | 811 | Q9BYK8 | |
| DCKNWQWGGLTCDHY | 451 | Q86VB7 | |
| TGCANMWGEYWDNLI | 1206 | Q9Y238 | |
| YQWDAETQGWILGSF | 101 | Q9NRA2 | |
| DYEARESWRQNTSWG | 496 | Q9BY12 | |
| QPYDNTVDWWCLGAV | 336 | Q96BR1 | |
| AECRCQSGEDWWYMG | 626 | Q16820 | |
| LWLNEGFASWIEYLC | 371 | P55786 | |
| WNLENRFSGWYDADL | 16 | P18669 | |
| ESWICGGQWREYFSA | 56 | Q96EK7 | |
| DQQTGKCRRVYSGWW | 81 | Q6PF18 | |
| GNWLRYVNWACSGEE | 96 | Q13029 | |
| FDQLYDAWRGGLDWC | 191 | P10915 | |
| DEDYPCSLVGNWNTW | 101 | Q9BPW8 | |
| CSLVGNWNTWYGEQD | 106 | Q9BPW8 | |
| SLDWEDWQYFARNCG | 406 | O75445 | |
| HVSWNDARAYCAWRG | 146 | Q8NBJ7 | |
| QTGYNKLCDWWSLGV | 296 | Q15208 | |
| LAIIGGVCYSWGWNE | 346 | Q9UGK8 | |
| NAYDESWGQDGIWIA | 151 | O14545 | |
| NNTEKGWDWYVCEGF | 66 | Q53T94 | |
| WNQENRFCGWFDAEL | 16 | P15259 | |
| EYCHGWLDAQGVWRI | 36 | Q6UWI4 | |
| LGQTPASVWYWCADQ | 266 | P53794 | |
| WLTEDCWLQANLYLG | 361 | Q9NY99 | |
| DQCGWWVVLLAYGTF | 401 | O75783 | |
| LGRIWQNFDSARWCG | 581 | Q8N122 | |
| DDWTVLCNGPYWVRD | 131 | Q99470 | |
| RYVSAGQSVACGWWA | 76 | Q96BD0 | |
| YNQAEGWKWGGCSAD | 141 | P56706 | |
| YQFAWDRWNCPERAL | 56 | Q93098 | |
| WNWVAALGSDDEYGR | 206 | Q7RTX0 | |
| YGSCGLENICLWKNW | 71 | Q8TB69 | |
| WYILEVADAGNGSAW | 31 | A6NFC5 | |
| VQWRTAYAGVCGFLW | 146 | Q2QL34 | |
| GLCYDTRNWNDEWDN | 156 | P21580 | |
| SWCEDVRYLGKNWSF | 246 | Q6ZMD2 | |
| LGLTIVSGWYWCSDQ | 281 | P31639 | |
| CGNNGFRDWFEIQWI | 166 | P23942 | |
| TTNEWYRGDWAWCQR | 286 | Q9NPG8 | |
| HGAWGYVCNQEWTLA | 46 | Q4G0T1 | |
| REGTCAGYAWNIKWR | 976 | Q86WI1 | |
| AGFYWCLTNGDTLWR | 436 | P01833 | |
| LNLVTRADEGWYWCG | 531 | P01833 | |
| RADEGWYWCGVKQGH | 536 | P01833 | |
| WCLPADWGDLQTYSR | 151 | Q8N841 | |
| EAWQWGGCGDNLKYS | 161 | O14904 | |
| RQSCPDGWEEWYQNN | 81 | P17031 | |
| FAFPCRWLAQNGEWA | 46 | Q8WVZ1 | |
| RWYQMGIVSWGEGCD | 581 | P00734 | |
| WCGYALASWSVQGAA | 206 | P18405 | |
| ENRTDCWVTGWGYIK | 166 | Q9Y6M0 | |
| YGECQEVLWWGGVFL | 121 | Q69YG0 | |
| RHGCNSGSIDRAWWY | 281 | Q9UJW2 | |
| KEDTGWYWCGIQRDF | 146 | P0DMS9 | |
| AWQWGVCGDNLKYST | 156 | O14905 | |
| AVDWGWQGLIAYGCH | 26 | Q9BZH6 | |
| WYLIGIVSWGDNCGQ | 381 | Q6ZMR5 | |
| NIRWESAYVWCVQGT | 336 | Q86SH2 | |
| IQRYIWDGESNCEWS | 941 | Q5VV43 | |
| YDVWLGNSRGNTWSR | 111 | Q5VXJ0 |